secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2024-03-21T23:59:59+00:00
Accession:  0001104659-24-037406
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio raises $3M via registered direct offering of 316,455 shares at $9.48/share
--------------------------------------------------------------------------------

- Sold 316,455 common shares at $9.48 each for $3.0M gross proceeds under effective Form S-3 shelf registration.
- 30-day post-closing lock-up restricts new equity issuances, warrant amendments, registration filings, and variable-rate deals.
- Closing contingent on NYSE listing of the offered shares; expected promptly after conditions satisfied.
- Buyer may sell shares during pre-settlement period and remains unconditionally bound to purchase at closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924037406/0001104659-24-037406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924037406/tm249453d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-037406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer